Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Zolpidem Hemitartarate 3.5 mg in Healthy Volunteers
NCT02817750Phase 1Completed
- Sponsor
- Biolab Farmacêutica
- Start
- Jul 2017
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of zolpidem sublingual tablet in Insomnia (2 arms), sponsored by Biolab Farmacêutica. Primary endpoints: Area under the curve (0-last) at 24 hours, Area under the curve (0-inf) at 24 hours and 6 more. Started Jul 2017; status: completed.
02
Drugs
zolpidem sublingual tablet
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02817750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817750.